Circulating fibrinogen is a prognostic and predictive biomarker in malignant pleural mesothelioma

被引:0
|
作者
B Ghanim
M A Hoda
T Klikovits
M-P Winter
A Alimohammadi
M Grusch
B Dome
M Arns
P Schenk
M Jakopovic
M Samarzija
L Brcic
M Filipits
V Laszlo
W Klepetko
W Berger
B Hegedus
机构
[1] Medical University of Vienna,Division of Thoracic Surgery, Department of Surgery
[2] Institute of Cancer Research,Department of Internal Medicine I
[3] Medical University of Vienna,Department of Thoracic Surgery
[4] National Koranyi Institute of Pulmonology,Department of Pulmonology
[5] National Institute of Oncology,Department for Respiratory Diseases Jordanovac
[6] LKH Hochegg,Department of Biological Physics
[7] University of Zagreb,undefined
[8] School of Medicine,undefined
[9] University Hospital Center,undefined
[10] University of Zagreb,undefined
[11] School of Medicine,undefined
[12] Institute of Pathology,undefined
[13] Eötvös University,undefined
[14] MTA-SE Molecular Oncology Research Group,undefined
[15] Hungarian Academy of Sciences,undefined
来源
British Journal of Cancer | 2014年 / 110卷
关键词
malignant pleural mesothelioma; fibrinogen; prognosis; predictive biomarker; multimodality therapy;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:984 / 990
页数:6
相关论文
共 50 条
  • [1] Circulating fibrinogen is a prognostic and predictive biomarker in malignant pleural mesothelioma
    Ghanim, B.
    Hoda, M. A.
    Klikovits, T.
    Winter, M-P
    Alimohammadi, A.
    Grusch, M.
    Dome, B.
    Arns, M.
    Schenk, P.
    Jakopovic, M.
    Samarzija, M.
    Brcic, L.
    Filipits, M.
    Laszlo, V.
    Klepetko, W.
    Berger, W.
    Hegedus, B.
    BRITISH JOURNAL OF CANCER, 2014, 110 (04) : 984 - 990
  • [2] A critical update on prognostic and predictive biomarkers in malignant pleural mesothelioma
    Ghanim B.
    Hoda M.A.
    Klikovits T.
    Dome B.
    Grusch M.
    Filipits M.
    Klepetko W.
    Berger W.
    Hegedus B.
    memo - Magazine of European Medical Oncology, 2015, 8 (1) : 52 - 56
  • [3] Circulating activin A is a novel prognostic biomarker in malignant pleural mesothelioma - A multi-institutional study
    Hoda, Mir Alireza
    Dong, Yawen
    Rozsas, Anita
    Klikovits, Thomas
    Laszlo, Viktoria
    Ghanim, Bahil
    Stockhammer, Paul
    Ozsvar, Judit
    Jakopovic, Marko
    Samarzija, Miroslav
    Brcic, Luka
    Bendek, Matyas
    Szirtes, Ildiko
    Reid, Glen
    Kirschner, Michaela B.
    Kao, Steven C.
    Opitz, Isabelle
    Weder, Walter
    Frauenfelder, Thomas
    Thi Dan Linh Nguyen-Kim
    Aigner, Clemens
    Klepetko, Walter
    van Zandwijk, Nico
    Berger, Walter
    Dome, Balazs
    Grusch, Michael
    Hegedus, Balazs
    EUROPEAN JOURNAL OF CANCER, 2016, 63 : 64 - 73
  • [4] Fibulin-3: A Potential Prognostic Biomarker in Malignant Pleural Mesothelioma?
    Kirschner, Michaela B.
    Pulford, Emily
    Hoda, Mir A.
    Rozsas, Anita
    Griggs, Kim
    Edelman, J. James B.
    Kao, Steven
    Hyland, Rebecca
    Dong, Yawen
    Laszlo, Viktoria
    Klikovits, Thomas
    Jakopovic, Marko
    Vallely, Michael
    Grusch, Michael
    Hegedus, Balazs
    Dome, Balazs
    Klepetko, Walter
    Van Zandwijk, Nico
    Klebe, Sonja
    Reid, Glen
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S747 - S747
  • [5] Plasma Biomarker Enrichment of Clinical Prognostic Indices in Malignant Pleural Mesothelioma
    Pass, Harvey I.
    Goparaju, Chandra
    Espin-Garcia, Osvaldo
    Donington, Jessica
    Carbone, Michele
    Patel, Devalben
    Chen, Zhuo
    Feld, Ronald
    Cho, John
    Gadgeel, Shirish
    Wozniak, Antoinette
    Chachoua, Abraham
    Leighl, Natasha
    Tsao, Ming-Sound
    de Perrot, Marc
    Xu, Wei
    Liu, Geoffrey
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (06) : 900 - 909
  • [6] Prognostic factors for malignant pleural mesothelioma
    Fraser J. H. Brims
    Nick A. Maskell
    Current Respiratory Care Reports, 2013, 2 (2): : 100 - 108
  • [7] Prognostic factors for malignant pleural mesothelioma
    Brims, Fraser J. H.
    Maskell, Nick A.
    CURRENT PULMONOLOGY REPORTS, 2013, 2 (02) : 100 - 108
  • [8] Prognostic factors in malignant pleural mesothelioma
    Davidson, Ben
    HUMAN PATHOLOGY, 2015, 46 (06) : 789 - 804
  • [9] Prognostic Factors in Malignant Pleural Mesothelioma
    Kirschner, M.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S12 - S12
  • [10] Detection of circulating immunosuppressive cytokines in malignant pleural mesothelioma patients for prognostic stratification
    Urso, Loredana
    Silic-Benussi, Micol
    Boscolo, Alice
    Lorenzi, Martina
    Bonanno, Laura
    Lunardi, Francesca
    Guarneri, Valentina
    Calabrese, Fiorella
    Rea, Federico
    Conte, PierFranco
    Pasello, Giulia
    CYTOKINE, 2021, 146